董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Hermann Lubbert | 男 | Chairman and Chief Executive Officer | 63 | 72.76万欧元 | 未持股 | 2019-04-29 |
| Thomas Schaffer | 男 | CFO and Director | 56 | 51.16万欧元 | 未持股 | 2019-04-29 |
| Christoph Dunwald | 男 | CCO and Director | 51 | 43.22万欧元 | 未持股 | 2019-04-29 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Hermann Lubbert | 男 | Chairman and Chief Executive Officer | 63 | 72.76万欧元 | 未持股 | 2019-04-29 |
| Thomas Schaffer | 男 | CFO and Director | 56 | 51.16万欧元 | 未持股 | 2019-04-29 |
| Christoph Dunwald | 男 | CCO and Director | 51 | 43.22万欧元 | 未持股 | 2019-04-29 |
董事简历
中英对照 | 中文 | 英文- Hermann Lubbert
-
Hermann Lubbert是Biofrontera AG的管理委员会主席、首席执行官以及Biofrontera Bioscience GmbH和Biofrontera Pharma GmbH的常务董事。他在家乡科隆学习生物学，并于1984年获得博士学位。
Hermann Lubbert Ph.D. founded Biofrontera AG in 1997 and has served as Biofrontera Inc.’s Executive Chairman since November 2021 and as chairman of its board of directors since March 2015. Until December 2021 Prof. Dr. Lübbert had served as the chief executive officer of Biofrontera AG, chairman of the management board of Biofrontera AG, and as a managing director of all subsidiaries of Biofrontera AG. Prof. Dr. Lübbert has also served as the chief executive officer of Biofrontera Inc. March 2015 - January 2020; March 2021-November 2021 and as the chairman of Biofrontera Inc.’s board of directors (March 2015-present). He studied biology in his hometown of Cologne and received his doctorate there in 1984. Following 3.5 years in academic research at the University of Cologne and the California Institute of Technology, he gained experience in managing a global research organization during 10 years at Sandoz, where he served as Head of Genome Research, and Novartis Pharma AG, where he served as a member of the global Neuroscience Research Management Team. He qualified as a university lecturer at the Swiss Federal Institute of Technology (ETH) Zurich and in addition to his engagements at Biofrontera held a professorship for animal physiology at the Ruhr-University Bochum from which he retired on February 28 2022. - Hermann Lubbert是Biofrontera AG的管理委员会主席、首席执行官以及Biofrontera Bioscience GmbH和Biofrontera Pharma GmbH的常务董事。他在家乡科隆学习生物学，并于1984年获得博士学位。
- Hermann Lubbert Ph.D. founded Biofrontera AG in 1997 and has served as Biofrontera Inc.’s Executive Chairman since November 2021 and as chairman of its board of directors since March 2015. Until December 2021 Prof. Dr. Lübbert had served as the chief executive officer of Biofrontera AG, chairman of the management board of Biofrontera AG, and as a managing director of all subsidiaries of Biofrontera AG. Prof. Dr. Lübbert has also served as the chief executive officer of Biofrontera Inc. March 2015 - January 2020; March 2021-November 2021 and as the chairman of Biofrontera Inc.’s board of directors (March 2015-present). He studied biology in his hometown of Cologne and received his doctorate there in 1984. Following 3.5 years in academic research at the University of Cologne and the California Institute of Technology, he gained experience in managing a global research organization during 10 years at Sandoz, where he served as Head of Genome Research, and Novartis Pharma AG, where he served as a member of the global Neuroscience Research Management Team. He qualified as a university lecturer at the Swiss Federal Institute of Technology (ETH) Zurich and in addition to his engagements at Biofrontera held a professorship for animal physiology at the Ruhr-University Bochum from which he retired on February 28 2022.
- Thomas Schaffer
-
Thomas Schaffer的职业生涯始于西门子半导体（Siemens Semiconductor）的金融和控制领域的多个职位。他曾担任西门子安全和芯片卡集成电路领域的Vice President和首席财务官，随后在Infineon Ventures GmbH担任了四年的董事总经理和首席财务官，并继续担任Qimonda AG专业DRAM部门的Vice President和首席财务官，他还在Qimonda Solar GmbH担任董事总经理。他在担任芬兰/瑞士Heptagon Oy和美国特拉华州Ubidyne Inc.的首席财务官方面积累了丰富的国际经验。Schaffer先生自2013年6月起担任Biofrontera AG首席财务官。
Thomas Schaffer started his career in various positions in the finance and controlling area at Siemens Semiconductor. He was Vice President and CFO in the Security & Chipcard ICs area at Siemens.He was then Managing Director and CFO at Infineon Ventures GmbH for a four-year period and continued his career as Vice President and CFO of the Specialty DRAM Division of Qimonda AG, where he also assumed the Managing Director role at Qimonda Solar GmbH. He added to his significant international experience with appointments as CFO at Heptagon Oy, Finland/Switzerland, and Ubidyne Inc., Delaware, U.S.. Mr. Schaffer has been CFO of Biofrontera AG since June 2013. - Thomas Schaffer的职业生涯始于西门子半导体（Siemens Semiconductor）的金融和控制领域的多个职位。他曾担任西门子安全和芯片卡集成电路领域的Vice President和首席财务官，随后在Infineon Ventures GmbH担任了四年的董事总经理和首席财务官，并继续担任Qimonda AG专业DRAM部门的Vice President和首席财务官，他还在Qimonda Solar GmbH担任董事总经理。他在担任芬兰/瑞士Heptagon Oy和美国特拉华州Ubidyne Inc.的首席财务官方面积累了丰富的国际经验。Schaffer先生自2013年6月起担任Biofrontera AG首席财务官。
- Thomas Schaffer started his career in various positions in the finance and controlling area at Siemens Semiconductor. He was Vice President and CFO in the Security & Chipcard ICs area at Siemens.He was then Managing Director and CFO at Infineon Ventures GmbH for a four-year period and continued his career as Vice President and CFO of the Specialty DRAM Division of Qimonda AG, where he also assumed the Managing Director role at Qimonda Solar GmbH. He added to his significant international experience with appointments as CFO at Heptagon Oy, Finland/Switzerland, and Ubidyne Inc., Delaware, U.S.. Mr. Schaffer has been CFO of Biofrontera AG since June 2013.
- Christoph Dunwald
-
Christoph Dunwald的职业生涯始于拜耳公司（Bayer AG），在那里，他在美国和西班牙市场营销以及德国和东南亚的战略业务管理方面担任了15年的多个职位。他曾管理比利时和卢森堡的拜耳梦百合诊断部门，担任总经理。在为Corporació；n Dermoesté；tica SA担任了两年的西班牙和英国国际销售与市场营销总监后，他于2008年转任美国制药集团Allergan的高级商务总监。从2009年到2015年，他管理其在西班牙和葡萄牙的医疗业务部门。
Christoph Dunwald started his career at Bayer AG, where he held various positions in marketing U.S. and Spain and in strategic business management in Germany and Southeast Asia over a 15-year period.In his last position at Bayer, he managed the Bayer Healthcare Diagnostics Division in Belgium and Luxembourg as General Manager. After two years as International Sales and Marketing Director in Spain and England for Corporación Dermoestética SA, he moved to become Senior Commercial Director at U.S. pharmaceuticals group Allergan in 2008. From 2009 until 2015 he managed its Medical Business Unit in Spain and Portugal. - Christoph Dunwald的职业生涯始于拜耳公司（Bayer AG），在那里，他在美国和西班牙市场营销以及德国和东南亚的战略业务管理方面担任了15年的多个职位。他曾管理比利时和卢森堡的拜耳梦百合诊断部门，担任总经理。在为Corporació；n Dermoesté；tica SA担任了两年的西班牙和英国国际销售与市场营销总监后，他于2008年转任美国制药集团Allergan的高级商务总监。从2009年到2015年，他管理其在西班牙和葡萄牙的医疗业务部门。
- Christoph Dunwald started his career at Bayer AG, where he held various positions in marketing U.S. and Spain and in strategic business management in Germany and Southeast Asia over a 15-year period.In his last position at Bayer, he managed the Bayer Healthcare Diagnostics Division in Belgium and Luxembourg as General Manager. After two years as International Sales and Marketing Director in Spain and England for Corporación Dermoestética SA, he moved to become Senior Commercial Director at U.S. pharmaceuticals group Allergan in 2008. From 2009 until 2015 he managed its Medical Business Unit in Spain and Portugal.
高管简历
中英对照 | 中文 | 英文- Hermann Lubbert
Hermann Lubbert是Biofrontera AG的管理委员会主席、首席执行官以及Biofrontera Bioscience GmbH和Biofrontera Pharma GmbH的常务董事。他在家乡科隆学习生物学，并于1984年获得博士学位。
Hermann Lubbert Ph.D. founded Biofrontera AG in 1997 and has served as Biofrontera Inc.’s Executive Chairman since November 2021 and as chairman of its board of directors since March 2015. Until December 2021 Prof. Dr. Lübbert had served as the chief executive officer of Biofrontera AG, chairman of the management board of Biofrontera AG, and as a managing director of all subsidiaries of Biofrontera AG. Prof. Dr. Lübbert has also served as the chief executive officer of Biofrontera Inc. March 2015 - January 2020; March 2021-November 2021 and as the chairman of Biofrontera Inc.’s board of directors (March 2015-present). He studied biology in his hometown of Cologne and received his doctorate there in 1984. Following 3.5 years in academic research at the University of Cologne and the California Institute of Technology, he gained experience in managing a global research organization during 10 years at Sandoz, where he served as Head of Genome Research, and Novartis Pharma AG, where he served as a member of the global Neuroscience Research Management Team. He qualified as a university lecturer at the Swiss Federal Institute of Technology (ETH) Zurich and in addition to his engagements at Biofrontera held a professorship for animal physiology at the Ruhr-University Bochum from which he retired on February 28 2022.- Hermann Lubbert是Biofrontera AG的管理委员会主席、首席执行官以及Biofrontera Bioscience GmbH和Biofrontera Pharma GmbH的常务董事。他在家乡科隆学习生物学，并于1984年获得博士学位。
- Hermann Lubbert Ph.D. founded Biofrontera AG in 1997 and has served as Biofrontera Inc.’s Executive Chairman since November 2021 and as chairman of its board of directors since March 2015. Until December 2021 Prof. Dr. Lübbert had served as the chief executive officer of Biofrontera AG, chairman of the management board of Biofrontera AG, and as a managing director of all subsidiaries of Biofrontera AG. Prof. Dr. Lübbert has also served as the chief executive officer of Biofrontera Inc. March 2015 - January 2020; March 2021-November 2021 and as the chairman of Biofrontera Inc.’s board of directors (March 2015-present). He studied biology in his hometown of Cologne and received his doctorate there in 1984. Following 3.5 years in academic research at the University of Cologne and the California Institute of Technology, he gained experience in managing a global research organization during 10 years at Sandoz, where he served as Head of Genome Research, and Novartis Pharma AG, where he served as a member of the global Neuroscience Research Management Team. He qualified as a university lecturer at the Swiss Federal Institute of Technology (ETH) Zurich and in addition to his engagements at Biofrontera held a professorship for animal physiology at the Ruhr-University Bochum from which he retired on February 28 2022.
- Thomas Schaffer
Thomas Schaffer的职业生涯始于西门子半导体（Siemens Semiconductor）的金融和控制领域的多个职位。他曾担任西门子安全和芯片卡集成电路领域的Vice President和首席财务官，随后在Infineon Ventures GmbH担任了四年的董事总经理和首席财务官，并继续担任Qimonda AG专业DRAM部门的Vice President和首席财务官，他还在Qimonda Solar GmbH担任董事总经理。他在担任芬兰/瑞士Heptagon Oy和美国特拉华州Ubidyne Inc.的首席财务官方面积累了丰富的国际经验。Schaffer先生自2013年6月起担任Biofrontera AG首席财务官。
Thomas Schaffer started his career in various positions in the finance and controlling area at Siemens Semiconductor. He was Vice President and CFO in the Security & Chipcard ICs area at Siemens.He was then Managing Director and CFO at Infineon Ventures GmbH for a four-year period and continued his career as Vice President and CFO of the Specialty DRAM Division of Qimonda AG, where he also assumed the Managing Director role at Qimonda Solar GmbH. He added to his significant international experience with appointments as CFO at Heptagon Oy, Finland/Switzerland, and Ubidyne Inc., Delaware, U.S.. Mr. Schaffer has been CFO of Biofrontera AG since June 2013.- Thomas Schaffer的职业生涯始于西门子半导体（Siemens Semiconductor）的金融和控制领域的多个职位。他曾担任西门子安全和芯片卡集成电路领域的Vice President和首席财务官，随后在Infineon Ventures GmbH担任了四年的董事总经理和首席财务官，并继续担任Qimonda AG专业DRAM部门的Vice President和首席财务官，他还在Qimonda Solar GmbH担任董事总经理。他在担任芬兰/瑞士Heptagon Oy和美国特拉华州Ubidyne Inc.的首席财务官方面积累了丰富的国际经验。Schaffer先生自2013年6月起担任Biofrontera AG首席财务官。
- Thomas Schaffer started his career in various positions in the finance and controlling area at Siemens Semiconductor. He was Vice President and CFO in the Security & Chipcard ICs area at Siemens.He was then Managing Director and CFO at Infineon Ventures GmbH for a four-year period and continued his career as Vice President and CFO of the Specialty DRAM Division of Qimonda AG, where he also assumed the Managing Director role at Qimonda Solar GmbH. He added to his significant international experience with appointments as CFO at Heptagon Oy, Finland/Switzerland, and Ubidyne Inc., Delaware, U.S.. Mr. Schaffer has been CFO of Biofrontera AG since June 2013.
- Christoph Dunwald
Christoph Dunwald的职业生涯始于拜耳公司（Bayer AG），在那里，他在美国和西班牙市场营销以及德国和东南亚的战略业务管理方面担任了15年的多个职位。他曾管理比利时和卢森堡的拜耳梦百合诊断部门，担任总经理。在为Corporació；n Dermoesté；tica SA担任了两年的西班牙和英国国际销售与市场营销总监后，他于2008年转任美国制药集团Allergan的高级商务总监。从2009年到2015年，他管理其在西班牙和葡萄牙的医疗业务部门。
Christoph Dunwald started his career at Bayer AG, where he held various positions in marketing U.S. and Spain and in strategic business management in Germany and Southeast Asia over a 15-year period.In his last position at Bayer, he managed the Bayer Healthcare Diagnostics Division in Belgium and Luxembourg as General Manager. After two years as International Sales and Marketing Director in Spain and England for Corporación Dermoestética SA, he moved to become Senior Commercial Director at U.S. pharmaceuticals group Allergan in 2008. From 2009 until 2015 he managed its Medical Business Unit in Spain and Portugal.- Christoph Dunwald的职业生涯始于拜耳公司（Bayer AG），在那里，他在美国和西班牙市场营销以及德国和东南亚的战略业务管理方面担任了15年的多个职位。他曾管理比利时和卢森堡的拜耳梦百合诊断部门，担任总经理。在为Corporació；n Dermoesté；tica SA担任了两年的西班牙和英国国际销售与市场营销总监后，他于2008年转任美国制药集团Allergan的高级商务总监。从2009年到2015年，他管理其在西班牙和葡萄牙的医疗业务部门。
- Christoph Dunwald started his career at Bayer AG, where he held various positions in marketing U.S. and Spain and in strategic business management in Germany and Southeast Asia over a 15-year period.In his last position at Bayer, he managed the Bayer Healthcare Diagnostics Division in Belgium and Luxembourg as General Manager. After two years as International Sales and Marketing Director in Spain and England for Corporación Dermoestética SA, he moved to become Senior Commercial Director at U.S. pharmaceuticals group Allergan in 2008. From 2009 until 2015 he managed its Medical Business Unit in Spain and Portugal.